Hypoxia-selective compounds for boron neutron capture therapy

Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2008.

Bibliographic Details
Main Author: Shah, Jungal (Jugal Kaushik)
Other Authors: Jeffrey A. Coderre.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2009
Subjects:
Online Access:http://hdl.handle.net/1721.1/44829
_version_ 1811091239822426112
author Shah, Jungal (Jugal Kaushik)
author2 Jeffrey A. Coderre.
author_facet Jeffrey A. Coderre.
Shah, Jungal (Jugal Kaushik)
author_sort Shah, Jungal (Jugal Kaushik)
collection MIT
description Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2008.
first_indexed 2024-09-23T14:59:16Z
format Thesis
id mit-1721.1/44829
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T14:59:16Z
publishDate 2009
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/448292019-04-10T16:36:01Z Hypoxia-selective compounds for boron neutron capture therapy Shah, Jungal (Jugal Kaushik) Jeffrey A. Coderre. Massachusetts Institute of Technology. Dept. of Nuclear Science and Engineering. Massachusetts Institute of Technology. Dept. of Nuclear Science and Engineering. Nuclear Science and Engineering. Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2008. "June 2008." Includes bibliographical references. Boron neutron capture therapy (BNCT) is a biochemically targeted form of radiotherapy for cancer. In BNCT, a compound labeled with the stable isotope boron-10 is systemically administered, and tumor cells selectively uptake the boron-10 containing compound at higher concentrations than normal cells. A general problem with the tumor seeking compounds is that drug delivery is dependent upon sufficient vascularization within the tumor. To investigate the possibility of delivering boron to hypoxic regions of tumor, a new boronated nitroimidazole delivery agent has been synthesized as a carrier of boron-10 for BNCT. It is expected that this will be used in combination with the existing boron carrier boronophenylalanine-fructose to treat solid tumors. An immunohistochemical protocol to visualize hypoxia was tested and refined to confirm the suitability of two tumor models established in the lab for hypoxia related uptake studies. The immunohistochemical protocol is used to detect pimonidazole, which localizes at hypoxic regions in tissue and is the parent compound for the new hypoxia-selective boron carrier. The protocol was used to test and confirm the suitability of a hypoxic in vivo tumor model. Two tumor lines were tested: SCCVII squamous cell carcinoma and EMT-6 murine mammary carcinoma. Both exhibited hypoxia. Finally, quantitative studies using Inductive Coupled Plasma Atomic Emission Spectrum demonstrated that the synthesized boronated nitroimidazole reaches suitable concentrations in SCCVII and F98 tumor. Future therapeutic studies are required to empirically confirm the effectiveness of this compound. by Jugal Shah. S.B. 2009-03-16T19:48:27Z 2009-03-16T19:48:27Z 2008 Thesis http://hdl.handle.net/1721.1/44829 301562235 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 39 p. application/pdf Massachusetts Institute of Technology
spellingShingle Nuclear Science and Engineering.
Shah, Jungal (Jugal Kaushik)
Hypoxia-selective compounds for boron neutron capture therapy
title Hypoxia-selective compounds for boron neutron capture therapy
title_full Hypoxia-selective compounds for boron neutron capture therapy
title_fullStr Hypoxia-selective compounds for boron neutron capture therapy
title_full_unstemmed Hypoxia-selective compounds for boron neutron capture therapy
title_short Hypoxia-selective compounds for boron neutron capture therapy
title_sort hypoxia selective compounds for boron neutron capture therapy
topic Nuclear Science and Engineering.
url http://hdl.handle.net/1721.1/44829
work_keys_str_mv AT shahjungaljugalkaushik hypoxiaselectivecompoundsforboronneutroncapturetherapy